{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:43:11Z","timestamp":1794660191387,"version":"4.9.1"},"reference-count":31,"publisher":"Baishideng Publishing Group Inc.","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastroenterol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>The albumin-bilirubin (ALBI) score is a marker of liver function and prognosis in hepatocellular carcinoma, with its utility being expanded to various liver conditions. However, its role in predicting long-term outcomes in patients with metabolic-associated steatotic liver disease (MASLD) remains unknown.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To determine the ability of the ALBI score in predicting the 8-year liver-related complications and all-cause mortality in MASLD.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>We conducted a retrospective longitudinal cohort study of 1163 patients with MASLD. MASLD was defined by a controlled attenuation parameter of &gt; 254 dB\/m on transient elastography, at least one cardiometabolic risk factor, and no excessive alcohol consumption. Odds ratio regression was employed to create based-prognostic scores with and without ALBI. The predictive accuracy of both scores, the ALBI score, and fibrosis-4 (FIB-4) were assessed using area under the receiving operating characteristic curve (AUROC) analysis and compared using the DeLong test.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>Over 8 years, 100 (8.6%) participants of liver-related complications, and 86 (7.4%) died (30.2% of prior liver complications). ALBI had greater accuracy for predicting liver-related complications [AUROC = 0.72, 95% confidence interval (CI): 0.66-0.77] compared with the based-prognostic score (AUROC = 0.67, 95%CI: 0.62-0.73) and FIB-4 (AUROC = 0.64, 95%CI: 0.58-0.70). Additionally, ALBI was superior to the based-prognostic score and FIB-4 (AUROC = 0.81, 95%CI: 0.76-0.86 vs  AUROC = 0.78, 95%CI: 0.72-0.83 and AUROC = 0.72, 95%CI: 0.65-0.78, respectively) for predicting all-cause mortality. Incorporating ALBI improved the prognostic score\u2019s accuracy for both outcomes (liver complications: AUROC = 0.74, 95%CI: 0.68-0.79; all-cause mortality: AUROC = 0.83, 95%CI: 0.79-0.88).<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>The ALBI score is a robust and independent predictor of long-term liver-related complications and all-cause mortality in patients with MASLD. ALBI may have potential clinical applications for long-term risk stratification in MASLD management.<\/jats:p>","DOI":"10.3748\/wjg.v31.i37.110829","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:27:13Z","timestamp":1758760033000},"source":"Crossref","is-referenced-by-count":9,"title":["Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease"],"prefix":"10.3748","volume":"31","author":[{"given":"Supatsri","family":"Sethasine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padoemwut","family":"Teerawongsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witchakorn","family":"Ruamtawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutachat","family":"Treerasoradaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huttakan","family":"Navadurong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027000"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.7904"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.01.011"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i32.4873"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12638"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13333"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74732-3"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263464"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2019.09.002"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2019.01212"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2024.07.415"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i31.109630"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12030665"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14564"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy153"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102639"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049325"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.21-080"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2019.12.003"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1163"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21470\/1678-9741-2022-0008"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34697"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101547"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S466469"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020163"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040978"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.057"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i41.4481"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i9.999"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i37\/110829.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i37\/110829.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:27:24Z","timestamp":1758760044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i37\/110829.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":31,"journal-issue":{"issue":"37"},"alternative-id":["110829"],"URL":"https:\/\/doi.org\/10.3748\/wjg.v31.i37.110829","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}